# Subcutaneous Ig in Allogeneic Stem Cell Transplant Recipients

> **NCT03401268** · NA · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 20 (actual)

## Conditions studied

- Hypogammaglobulinemia

## Interventions

- **DRUG:** subcutaneous immunoglobulin

## Key facts

- **NCT ID:** NCT03401268
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-01
- **Primary completion:** 2019-05-01
- **Final completion:** 2019-05-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03401268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03401268, "Subcutaneous Ig in Allogeneic Stem Cell Transplant Recipients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03401268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*